Structure via PubChem · Public domain (PubChem)
Cefixime
Sign in to saveAlso known as CL-284635, FK-027, FR-17027, cefixime anhydrous, (−)-cefixime, suprax
Cefixime, sold under the brand name Suprax among others, is an antibiotic medication used to treat a number of bacterial infections. These infections include otitis media, strep throat, pneumonia, urinary tract infections, gonorrhea, and Lyme disease. For gonorrhea typically only one dose is required. In the United States it is a second-line treatment to ceftriaxone for gonorrhea. It is taken by mouth.
In the Vinony graph
Within Vinony's link graph, Cefixime is referenced by 213 other articles, and connects out to antibiotic, ceftolozane/tazobactam and penicillin binding proteins.
It is catalogued under topics including Cephalosporin antibiotics, Dermatoxins and Drugboxes which contain changes to verified fields.
Its subject is documented across 30 Wikipedia language editions.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 460023156
- Drug.image
- Cefixime skeletal structure.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Cefixime ball-and-stick model from xtal 2013.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Suprax, others
- Drug.MedlinePlus
- a690007
- Drug.DailyMedID
- Cefixime
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
- J01
- Drug.ATC_suffix
- DD08
- Drug.legal_CA
- Rx-only
- Drug.legal_UK
- POM
- Drug.legal_US
- Rx-only
- Drug.legal_status
- Rx-only
- Drug.bioavailability
- 30 to 50%
via Wikipedia infobox
Chemical data
- Formula
- C16H15N5O7S2
- Molecular weight
- 453.5 g/mol
- IUPAC name
- (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- SMILES
- C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O
- InChIKey
- OKBVVJOGVLARMR-QSWIMTSFSA-N
- XLogP
- -0.7
- Polar surface area
- 238 Ų
- H-bond donors
- 4
- H-bond acceptors
- 12
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1989
- Admin. routes
- oral
- Indications
- Otitis media, infection, neoplasm, osteomyelitis
via ChEMBL · EBI
Wikidata facts
- Subclass of
- cephalosporin antibiotic
- Mass
- 453.04128982000003
- Has use
- medication
Show 9 more facts
- chemical formula
- C₁₆H₁₅N₅O₇S₂
- subject has role
- enzyme inhibitor
- medical condition treated
- otitis media
- canonical SMILES
- C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O
- isomeric SMILES
- C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O
- World Health Organisation international non-proprietary name
- cefixime
- NCI Thesaurus ID
- C1100
- defined daily dose
- 0.4
- Commons category
- Cefixime
Sources (7)
via Wikidata · CC0